Deepak Dalvie

6.0k total citations
76 papers, 4.0k citations indexed

About

Deepak Dalvie is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Deepak Dalvie has authored 76 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmacology, 31 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Deepak Dalvie's work include Pharmacogenetics and Drug Metabolism (38 papers), Drug Transport and Resistance Mechanisms (10 papers) and Inflammatory mediators and NSAID effects (6 papers). Deepak Dalvie is often cited by papers focused on Pharmacogenetics and Drug Metabolism (38 papers), Drug Transport and Resistance Mechanisms (10 papers) and Inflammatory mediators and NSAID effects (6 papers). Deepak Dalvie collaborates with scholars based in United States, United Kingdom and Germany. Deepak Dalvie's co-authors include Amit S. Kalgutkar, R. Scott Obach, John P. O’Donnell, S. Cyrus Khojasteh-Bakht, Ping Kang, Tim Taylor, Qiyue Hu, John P. O’Donnell, Michael Zientek and R. Foti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Deepak Dalvie

75 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Dalvie United States 33 1.7k 1.5k 831 609 607 76 4.0k
James L. Maggs United Kingdom 40 1.1k 0.7× 1.5k 1.0× 717 0.9× 653 1.1× 592 1.0× 109 4.5k
Deborah A. Nicoll‐Griffith Canada 26 1.1k 0.6× 1.2k 0.8× 495 0.6× 519 0.9× 335 0.6× 60 3.1k
Grover P. Miller United States 31 1.3k 0.8× 1.1k 0.7× 409 0.5× 408 0.7× 466 0.8× 97 2.8k
Ronald E. White United States 28 1.5k 0.9× 1.5k 1.0× 581 0.7× 668 1.1× 296 0.5× 70 3.8k
Neil R. Kitteringham United Kingdom 47 3.1k 1.8× 1.8k 1.2× 623 0.7× 937 1.5× 294 0.5× 92 7.3k
Jason K. Yano United States 20 1.6k 0.9× 1.9k 1.2× 466 0.6× 1.0k 1.7× 1.1k 1.8× 29 3.6k
Robert P. Hanzlik United States 38 2.1k 1.2× 1.6k 1.0× 1.4k 1.7× 746 1.2× 336 0.6× 159 5.1k
George A. Doss United States 29 876 0.5× 944 0.6× 681 0.8× 519 0.9× 233 0.4× 95 2.6k
Richard Weaver United Kingdom 36 1.2k 0.7× 1.7k 1.1× 241 0.3× 1.2k 2.0× 386 0.6× 86 3.9k
Thierry Cresteil France 41 1.8k 1.0× 1.7k 1.1× 1.1k 1.4× 1.3k 2.2× 187 0.3× 132 5.3k

Countries citing papers authored by Deepak Dalvie

Since Specialization
Citations

This map shows the geographic impact of Deepak Dalvie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Dalvie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Dalvie more than expected).

Fields of papers citing papers by Deepak Dalvie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Dalvie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Dalvie. The network helps show where Deepak Dalvie may publish in the future.

Co-authorship network of co-authors of Deepak Dalvie

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Dalvie. A scholar is included among the top collaborators of Deepak Dalvie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Dalvie. Deepak Dalvie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kramlinger, Valerie M., Deepak Dalvie, Amit S. Kalgutkar, et al.. (2021). Future of Biotransformation Science in the Pharmaceutical Industry. Drug Metabolism and Disposition. 50(3). 258–267. 12 indexed citations
3.
Dalvie, Deepak & Li Di. (2019). Aldehyde oxidase and its role as a drug metabolizing enzyme. Pharmacology & Therapeutics. 201. 137–180. 57 indexed citations
4.
Eng, Heather, Raman Sharma, Angela Wolford, et al.. (2016). Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes. Drug Metabolism and Disposition. 44(8). 1262–1269. 8 indexed citations
5.
Sokolowski, Sharon, et al.. (2015). Contribution of Membrane Trafficking Perturbation to Retinal Toxicity. Toxicological Sciences. 145(2). 383–395. 11 indexed citations
6.
Sharma, Raman, John Litchfield, Karen Atkinson, et al.. (2014). Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator. Drug Metabolism and Disposition. 42(11). 1926–1939. 15 indexed citations
7.
Schwartz, Phillip A., Petr Kuzmič, James Solowiej, et al.. (2013). Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance. Proceedings of the National Academy of Sciences. 111(1). 173–178. 197 indexed citations
8.
Loi, Cho‐Ming, Dennis A. Smith, & Deepak Dalvie. (2013). Which Metabolites Circulate?. Drug Metabolism and Disposition. 41(5). 933–951. 29 indexed citations
9.
Smith, Dennis A. & Deepak Dalvie. (2011). Why do metabolites circulate?. Xenobiotica. 42(1). 107–126. 30 indexed citations
10.
Shah, Manish B., et al.. (2010). Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4. Drug Metabolism and Disposition. 39(3). 539–550. 21 indexed citations
11.
12.
13.
Kang, Ping, Deepak Dalvie, Evan Smith, et al.. (2008). Bioactivation of Flutamide Metabolites by Human Liver Microsomes. Drug Metabolism and Disposition. 36(7). 1425–1437. 41 indexed citations
14.
Bu, Hai‐Zhi, Ping Zhao, Deepak Dalvie, & William F. Pool. (2007). Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(20). 3317–3322. 17 indexed citations
15.
Kalgutkar, Amit S., Deepak Dalvie, Jiri Aubrecht, et al.. (2007). Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation. Drug Metabolism and Disposition. 35(6). 848–858. 36 indexed citations
16.
O’Donnell, John P., Deepak Dalvie, Amit S. Kalgutkar, & R. Scott Obach. (2003). MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN. Drug Metabolism and Disposition. 31(11). 1369–1377. 56 indexed citations
17.
Dalvie, Deepak & John P. O’Donnell. (1999). Metabolism of CP-195,543, a leukotriene B4 receptor antagonist, in the Long-Evans rat and Cynomolgus monkey. Xenobiotica. 29(11). 1123–1140. 9 indexed citations
18.
Dalvie, Deepak & John P. O’Donnell. (1999). Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption. Xenobiotica. 29(10). 1043–1056. 3 indexed citations
19.
Sundberg, Richard J., et al.. (1993). Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds. Chemical Research in Toxicology. 6(4). 500–505. 7 indexed citations
20.
Zhao, Zhiyang, Deepak Dalvie, Noreen Naiman, Kay Castagnoli, & Neal Castagnoli. (1992). Design, synthesis, and biological evaluation of novel 4-substituted 1-methyl-1,2,3,6-tetrahydropyridine analogs of MPTP. Journal of Medicinal Chemistry. 35(23). 4473–4478. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James L. Maggs Breakdown of academic impact, for papers by Deborah A. Nicoll‐Griffith Breakdown of academic impact, for papers by Grover P. Miller Breakdown of academic impact, for papers by Ronald E. White Breakdown of academic impact, for papers by Neil R. Kitteringham Breakdown of academic impact, for papers by Jason K. Yano Breakdown of academic impact, for papers by Robert P. Hanzlik Breakdown of academic impact, for papers by George A. Doss Breakdown of academic impact, for papers by Richard Weaver Breakdown of academic impact, for papers by Thierry Cresteil
Rankless by CCL
2026